Overview
Emil Pedersen practices practicing medicine in Odense, Denmark.
His clinical expertise encompasses Myasthenia Gravis, Thymic Epithelial Tumor, and Congenital Myasthenic Syndrome.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Emil G. Pedersen
Is Emil G. Pedersen a top-rated expert for Myasthenia Gravis?
MediFind is an objective health platform that identifies experts based on real-world data. Emil G. Pedersen is classified as an Experienced expert for Myasthenia Gravis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Emil G. Pedersen participate in research or clinical trials?
Yes. Emil G. Pedersen has published 8 articles and abstracts on conditions like Myasthenia Gravis. You can view a list of Emil G. Pedersen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Congenital Myasthenic SyndromeMr. Pedersen isExperienced. Learn about Congenital Myasthenic Syndrome.
- Myasthenia GravisMr. Pedersen isExperienced. Learn about Myasthenia Gravis.
- Thymic Epithelial TumorMr. Pedersen isExperienced. Learn about Thymic Epithelial Tumor.